Cargando…

RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells

The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouzel, Ivan U., Kehl, Alexander, Berger, Petya, Liashkovich, Ivan, Steil, Daniel, Makalowski, Wojciech, Suzuki, Yutaka, Pohlentz, Gottfried, Karch, Helge, Mellmann, Alexander, Müthing, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080763/
https://www.ncbi.nlm.nih.gov/pubmed/32188865
http://dx.doi.org/10.1038/s41598-020-59694-w
_version_ 1783508058396164096
author Kouzel, Ivan U.
Kehl, Alexander
Berger, Petya
Liashkovich, Ivan
Steil, Daniel
Makalowski, Wojciech
Suzuki, Yutaka
Pohlentz, Gottfried
Karch, Helge
Mellmann, Alexander
Müthing, Johannes
author_facet Kouzel, Ivan U.
Kehl, Alexander
Berger, Petya
Liashkovich, Ivan
Steil, Daniel
Makalowski, Wojciech
Suzuki, Yutaka
Pohlentz, Gottfried
Karch, Helge
Mellmann, Alexander
Müthing, Johannes
author_sort Kouzel, Ivan U.
collection PubMed
description The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx becomes increasingly recognised, but how this exactly occurs is unknown. To explore this molecularly, we investigated the Stx receptor content and transcriptomic profile of two human renal epithelial cell lines: highly Stx-sensitive ACHN cells and largely Stx-insensitive Caki-2 cells. Though both lines exhibited the Stx receptor globotriaosylceramide, RNAseq revealed strikingly different transcriptomic responses to an Stx challenge. Using RNAi to silence factors involved in ACHN cells’ Stx response, the greatest protection occurred when silencing RAB5A and TRAPPC6B, two host factors that we newly link to Stx trafficking. Silencing these factors alongside YKT6 fully prevented the cytotoxic Stx effect. Overall, our approach reveals novel subcellular targets for potential therapies against Stx-mediated kidney failure.
format Online
Article
Text
id pubmed-7080763
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70807632020-03-23 RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells Kouzel, Ivan U. Kehl, Alexander Berger, Petya Liashkovich, Ivan Steil, Daniel Makalowski, Wojciech Suzuki, Yutaka Pohlentz, Gottfried Karch, Helge Mellmann, Alexander Müthing, Johannes Sci Rep Article The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx becomes increasingly recognised, but how this exactly occurs is unknown. To explore this molecularly, we investigated the Stx receptor content and transcriptomic profile of two human renal epithelial cell lines: highly Stx-sensitive ACHN cells and largely Stx-insensitive Caki-2 cells. Though both lines exhibited the Stx receptor globotriaosylceramide, RNAseq revealed strikingly different transcriptomic responses to an Stx challenge. Using RNAi to silence factors involved in ACHN cells’ Stx response, the greatest protection occurred when silencing RAB5A and TRAPPC6B, two host factors that we newly link to Stx trafficking. Silencing these factors alongside YKT6 fully prevented the cytotoxic Stx effect. Overall, our approach reveals novel subcellular targets for potential therapies against Stx-mediated kidney failure. Nature Publishing Group UK 2020-03-18 /pmc/articles/PMC7080763/ /pubmed/32188865 http://dx.doi.org/10.1038/s41598-020-59694-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kouzel, Ivan U.
Kehl, Alexander
Berger, Petya
Liashkovich, Ivan
Steil, Daniel
Makalowski, Wojciech
Suzuki, Yutaka
Pohlentz, Gottfried
Karch, Helge
Mellmann, Alexander
Müthing, Johannes
RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title_full RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title_fullStr RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title_full_unstemmed RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title_short RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
title_sort rab5a and trappc6b are novel targets for shiga toxin 2a inactivation in kidney epithelial cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080763/
https://www.ncbi.nlm.nih.gov/pubmed/32188865
http://dx.doi.org/10.1038/s41598-020-59694-w
work_keys_str_mv AT kouzelivanu rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT kehlalexander rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT bergerpetya rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT liashkovichivan rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT steildaniel rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT makalowskiwojciech rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT suzukiyutaka rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT pohlentzgottfried rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT karchhelge rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT mellmannalexander rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells
AT muthingjohannes rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells